학술논문
Efficacy of anifrolumab across organ domains in patients with moderate-to-severe systemic lupus erythematosus: a post-hoc analysis of pooled data from the TULIP-1 and TULIP-2 trials
Document Type
Article
Author
Source
In The Lancet Rheumatology April 2022 4(4):e282-e292
Subject
Language
ISSN
2665-9913